ORC6 and central nervous system cancer: In other primary glioma cells (P2/P3) and immortalized A172 cells, the application of shORC6-s1 (as shown in Fig. 4) for silencing ORC6 led to a similar increase in caspase-3 activity (Fig. 5K).